Molecular Imaging: Page 17

Getz Healthcare, Subtle Medical sign distribution deal

By AuntMinnieEurope.com staff writers

Australian medical equipment and software provider Getz Healthcare has signed on as a distributor for artificial intelligence (AI) software developer Subtle Medical.

March 29, 2023

Nuclidium wins award to study NET radiopharmaceutical

By AuntMinnieEurope.com staff writers

Radiopharmaceutical developer Nuclidium and the University Hospital Basel, Switzerland, have received an Investigator Award from the Neuroendocrine Tumors Research Foundation to support a phase I trial of its TraceNET copper-based diagnostic radiopharmaceutical for neuroendocrine tumors (NETs).

March 20, 2023

PET/CT reveals how COVID-19 manifests in critically ill patients

By Will Morton

A research group from the University of Groningen in the Netherlands has highlighted findings from whole-body F-18 FDG-PET/CT that show how COVID-19 manifests in critically ill patients.

March 20, 2023

World Molecular Imaging Society mourns death of Elliott Lasser

By AuntMinnieEurope.com staff writers

The World Molecular Imaging Society is mourning the death of Dr. Elliott Lasser, known for his contributions to contrast agent research.

March 19, 2023

Curium comments on supply challenges for Eclipse clinical trial

By AuntMinnieEurope.com staff writers

Nuclear medicine company Curium confirmed in a recent statement that it doesn't expect supply challenges of its lutetium-177 prostate-specific membrane antigen with 3-iodo-D-tyrosine for the company's Eclipse phase III clinical trial.

March 19, 2023

AuntMinnieEurope.com Molecular Imaging Insider

By Will Morton

March 14, 2023

Hybrid PET/CT scanners: An imaging revolution or more hype?

By Will Morton

Total-body and long axial field-of-view PET/CT scanners have the potential to dramatically improve imaging in patients, but can they be considered a revolution in the field? That question was debated during a discussion at ECR 2023 in Vienna.

March 14, 2023

Will lecanemab approval increase PET scan volumes?

By Will Morton

Europe could see increased demand for PET imaging if the monoclonal antibody lecanemab receives regulatory approval for the treatment of Alzheimer's disease, the European Association for Nuclear Medicine has stated.

March 12, 2023

GE HealthCare focuses on upgrades and 'experiences' at ECR 2023

By Erik L. Ridley and Frances Rylands-Monk

VIENNA - At ECR 2023, GE HealthCare showcased a range of new imaging hardware and software, as well as "immersive experiences." For the first time, it participated in an ECR as an independent public traded company.

March 4, 2023

Turn it off! Idle machines waste energy

By Will Morton

Radiology departments can help to reduce the impact of climate change by turning off unused imaging scanners and workstations during off hours, Swiss investigators have reported at ECR 2023.

March 3, 2023

Positron emission mammography receives attention at ECR 2023

By Amerigo Allegretto

New research findings presented at an ECR session held on 2 March have revealed that positron emission mammography allows for more accurate evaluation of breast cancer's response to chemotherapy, as well as residual tissue.

March 3, 2023

FDG-PET/CT reveals sites of COVID-19 brain infection

By Will Morton

FDG-PET/CT imaging shows metabolic neurologic changes due to COVID-19 in patients before the onset of anatomical abnormalities and can detect more active infection sites than MRI, according to research presented on 2 March at ECR 2023 in Vienna.

March 2, 2023

Previous Page

Page 17 of 121

Next Page